From: Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
 | All combined (%) | Allopurinol use (%) | |
---|---|---|---|
 |  | Current‡ | Previous‡ |
Total person days | 3,724,768 | 2,053,185 | 1,671,583 |
Male gender | 53.76 | 54.00 | 53.47 |
Age group | |||
  ≤ 50 | 7.55 | 6.54 | 8.79 |
 51–60 | 12.86 | 11.66 | 14.33 |
 61–65 | 9.70 | 9.32 | 10.17 |
 66–70 | 24.00 | 24.68 | 23.16 |
 71–75 | 19.73 | 20.12 | 19.26 |
 76–80 | 14.16 | 14.41 | 13.86 |
  > 80 | 12.00 | 13.27 | 10.44 |
Race | |||
 Asian | 4.49 | 4.29 | 4.73 |
 Black | 19.68 | 16.83 | 23.18 |
 Hispanic | 2.61 | 2.01 | 3.35 |
 Other | 1.87 | 1.78 | 1.98 |
 Missing | 4.89 | 4.26 | 5.67 |
 White | 66.46 | 70.83 | 61.09 |
Comorbidity | |||
 Hypertension | 85.57 | 85.35 | 85.85 |
 COPD | 9.12 | 9.00 | 9.27 |
 Renal disease | 26.11 | 27.71 | 24.14 |
 PVD | 8.12 | 8.17 | 8.05 |
 Hyperlipidemia* | 79.56 | 80.53 | 78.38 |